Table 1. Subject and scan data.
| Subject | Gender | Age (years) | Weight (kg) | Act Inj (mCi) | Mass Inj (μg) | SA (mCi/μmol) | Gray-matter CBF (mL per 100 mg per minute) |
|---|---|---|---|---|---|---|---|
| 1 | M | 35 | 73 | 9.91 | 1.13 | 2,738.33 | 57±30 |
| 2 | F | 19 | 60 | 9.24 | 1.93 | 1,488.80 | 86±19 |
| 3 | F | 23 | 54 | 9.43 | 1.14 | 2,583.31 | 74±15 |
| 4 | M | 53 | 89 | 9.41 | 2.05 | 1,431.32 | 33±9 |
| 5 | F | 42 | 77 | 10.28 | 2.2 | 1,456.82 | 70±14 |
| 6 | M | 28 | 70 | 10.05 | 1.24 | 2,518.63 | 66±14 |
CBF, cerebral blood flow; SA, specific activity.
CBF is the measure using the technique of continuous arterial spin labeling and average in a region including cortical gray matter, striatal gray matter, and cerebellum gray matter.